The relation between long-term cortisol levels and the metabolic syndrome in HIV-infected patients

Clinical Endocrinology

Volumn 83, Issue 2, 2015, Pages 167-172

  Langerak, Thomas ^a,b   Van Den Dries, Lennert W J ^a   Wester, Vincent L ^a,b   Staufenbiel, Sabine M ^a,b   Manenschijn, Laura ^a   Van Rossum, Elisabeth F C ^a,b   Van Gorp, Eric C M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Obesity Center CGG   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; GLUCOCORTICOID RECEPTOR; GLUCOSE BLOOD LEVEL;

ADULT; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DYSLIPIDEMIA; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HAIR LEVEL; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HYPERTENSION; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PRIORITY JOURNAL; ANALYSIS; ANTHROPOMETRY; BLOOD; COHORT ANALYSIS; COMPLICATION; CROSS-SECTIONAL STUDY; GLUCOSE BLOOD LEVEL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; METABOLISM; MIDDLE AGED; ODDS RATIO;

ADULT; ANTHROPOMETRY; BLOOD GLUCOSE; COHORT STUDIES; CROSS-SECTIONAL STUDIES; DYSLIPIDEMIAS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HIV INFECTIONS; HUMANS; HYDROCORTISONE; HYPERTENSION; INSULIN RESISTANCE; MALE; METABOLIC SYNDROME X; MIDDLE AGED; ODDS RATIO; RECEPTORS, GLUCOCORTICOID;

EID: 84937163407     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12790     Document Type: Article

References (37)

1. Carr, A., &, Cooper, D.A., (2000) Adverse effects of antiretroviral therapy. Lancet, 356, 1423-1430.
2. Bernasconi, E., Boubaker, K., Junghans, C., et al,. (2002) Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study. Journal of Acquired Immune Deficiency Syndromes, 31, 50-55.
3. Lo, J.C., Mulligan, K., Tai, V.W., et al,. (1998) "Buffalo hump" in men with HIV-1 infection. Lancet, 351, 867-870.
4. Grinspoon, S., &, Carr, A., (2005) Cardiovascular risk and body-fat abnormalities in HIV-infected adults. New England Journal of Medicine, 352, 48-62.
5. Periard, D., Telenti, A., Sudre, P., et al,. (1999) Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study. Circulation, 100, 700-705.
6. Carr, A., Samaras, K., Burton, S., et al,. (1998) A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS, 12, F51-F58.
7. Friis-Moller, N., Sabin, C.A., Weber, R., et al,. (2003) Combination antiretroviral therapy and the risk of myocardial infarction. New England Journal of Medicine, 349, 1993-2003.
8. Nieman, L.K., Biller, B.M., Findling, J.W., et al,. (2008) The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism, 93, 1526-1540.
9. Newell-Price, J., Trainer, P., Besser, M., et al,. (1998) The diagnosis and differential diagnosis of Cushing's syndrome and pseudo-Cushing's states. Endocrine Reviews, 19, 647-672.
10. Collazos, J., Mayo, J., Martinez, E., et al,. (2003) Serum cortisol in HIV-infected patients with and without highly active antiretroviral therapy. AIDS, 17, 123-126.
11. Christeff, N., Melchior, J.C., de Truchis, P., et al,. (1999) Lipodystrophy defined by a clinical score in HIV-infected men on highly active antiretroviral therapy: correlation between dyslipidaemia and steroid hormone alterations. AIDS, 13, 2251-2260.
12. Yanovski, J.A., Miller, K.D., Kino, T., et al,. (1999) Endocrine and Metabolic Evaluation of Human Immunodeficiency Virus-Infected Patients with Evidence of Protease Inhibitor-Associated Lipodystrophy. Journal of Clinical Endocrinology & Metabolism, 84, 1925-1931.
13. Andersen, O., Pedersen, S.B., Svenstrup, B., et al,. (2007) Circulating sex hormones and gene expression of subcutaneous adipose tissue oestrogen and alpha-adrenergic receptors in HIV-lipodystrophy: implications for fat distribution. Clinical Endocrinology (Oxford), 67, 250-258.
14. Weitzman, E.D., Fukushima, D., Nogeire, C., et al,. (1971) Twenty-four hour pattern of the episodic secretion of cortisol in normal subjects. Journal of Clinical Endocrinology and Metabolism, 33, 14-22.
15. Wennig, R., (2000) Potential problems with the interpretation of hair analysis results. Forensic Science International, 107, 5-12.
16. Manenschijn, L., Koper, J.W., Lamberts, S.W.J., et al,. (2011) Evaluation of a method to measure long term cortisol levels. Steroids, 76, 1032-1036.
17. Matthews, D.R., Hosker, J.P., Rudenski, A.S., et al,. (1985) Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia, 28, 412-419.
18. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (2002) Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation, 106, 3143-3421.
19. Groeneveld, M.G., Vermeer, H.J., Linting, M., et al,. (2013) Children's hair cortisol as a biomarker of stress at school entry. Stress, 16, 711-715.
20. Stalder, T., Kirschbaum, C., Alexander, N., et al,. (2013) Cortisol in hair and the metabolic syndrome. Journal of Clinical Endocrinology and Metabolism, 98, 2573-2580.
21. Manenschijn, L., Schaap, L., van Schoor, N.M., et al,. (2013) High long-term cortisol levels, measured in scalp hair, are associated with a history of cardiovascular disease. Journal of Clinical Endocrinology and Metabolism, 98, 2078-2083.
22. Fraser, R., Ingram, M.C., Anderson, N.H., et al,. (1999) Cortisol effects on body mass, blood pressure, and cholesterol in the general population. Hypertension, 33, 1364-1368.
23. Kino, T., De Martino, M.U., Charmandari, E., et al,. (2003) Tissue glucocorticoid resistance/hypersensitivity syndromes. Journal of Steroid Biochemistry and Molecular Biology, 85, 457-467.
24. Seckl, J.R., &, Walker, B.R., (2001) Minireview: 11beta-hydroxysteroid dehydrogenase type 1- a tissue-specific amplifier of glucocorticoid action. Endocrinology, 142, 1371-1376.
25. Tomlinson, J.W., Moore, J., Cooper, M.S., et al,. (2001) Regulation of expression of 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue: tissue-specific induction by cytokines. Endocrinology, 142, 1982-1989.
26. Escher, G., Galli, I., Vishwanath, B.S., et al,. (1997) Tumor necrosis factor alpha and interleukin 1beta enhance the cortisone/cortisol shuttle. Journal of Experimental Medicine, 186, 189-198.
27. Sutinen, J., Kannisto, K., Korsheninnikova, E., et al,. (2004) In the lipodystrophy associated with highly active antiretroviral therapy, pseudo-Cushing's syndrome is associated with increased regeneration of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 in adipose tissue. Diabetologia, 47, 1668-1671.
28. Bukrinsky, M., &, Adzhubei, A., (1999) Viral protein R of HIV-1. Reviews in Medical Virology, 9, 39-49.
29. Refaeli, Y., Levy, D.N., &, Weiner, D.B., (1995) The glucocorticoid receptor type II complex is a target of the HIV-1 vpr gene product. Proceedings of the National Academy of Sciences of the United States of America, 92, 3621-3625.
30. Eagling, V.A., Back, D.J., &, Barry, M.G., (1997) Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir. British Journal of Clinical Pharmacology, 44, 190-194.
31. von Moltke, L.L., Greenblatt, D.J., Grassi, J.M., et al,. (1998) Protease inhibitors as inhibitors of human cytochromes P450: high risk associated with ritonavir. Journal of Clinical Pharmacology, 38, 106-111.
32. Barry, M., Mulcahy, F., Merry, C., et al,. (1999) Pharmacokinetics and potential interactions amongst antiretroviral agents used to treat patients with HIV infection. Clinical Pharmacokinetics, 36, 289-304.
33. Russell, E., Kirschbaum, C., Laudenslager, M.L., et al,. (2015) Toward standardization of hair cortisol measurement: results of the first international interlaboratory round robin. Therapeutic Drug Monitoring, 37, 71-75.
34. Manenschijn, L., Koper, J.W., van den Akker, E.L., et al,. (2012) A novel tool in the diagnosis and follow-up of (cyclic) Cushing's syndrome: measurement of long-term cortisol in scalp hair. Journal of Clinical Endocrinology and Metabolism, 97, E1836-E1843.
35. Pereg, D., Gow, R., Mosseri, M., et al,. (2011) Hair cortisol and the risk for acute myocardial infarction in adult men. Stress, 14, 73-81.
36. Wester, V.L., Staufenbiel, S.M., Veldhorst, M.A., et al,. (2014) Long-term cortisol levels measured in scalp hair of obese patients. Obesity (Silver Spring), 22, 1956-1958.
37. Russcher, H., Smit, P., van Rossum, E.F., et al,. (2006) Strategies for the characterization of disorders in cortisol sensitivity. Journal of Clinical Endocrinology and Metabolism, 91, 694-701.